A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: OAG | eyes | eye | glaucoma | open-angle glaucoma | ocular hypertension | OHT | POAG | vision
Age: Between 18 - 100 Years
Gender: Male or Female
pigmentary glaucoma) or OHT in the study eye, requiring IOP-lowering treatment
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required